Many addiction treatment programs promise results — but few have the statistics to back up their claims. In fact, statistics show that most traditional opioid treatment programs aren’t working effectively, with up to 80% of opioid users relapsing after treatment.
Through our pioneering Symetria Method® – an innovative outpatient model that combines discreet and confidential Medicated Assisted Therapy (MAT) with behavioral counseling, group therapy, support groups, and continuing care resources in an outpatient setting — we have consistently achieved proven, measurable results that outperform all industry benchmarks.
Our success is your success.
Research shows that Symetria Recovery’s treatment model is scientifically designed to produce the best clinical outcomes.2
- Only 11% of Symetria Recovery patients have relapsed or returned-to-use. This is compared to universal statistics for opioid-dependent patients where the relapse rate can be as high as 90%.
- 86% of Symetria Recovery patients remain treatment adherent after six months, as compared to other programs that typically experience dropout rates of 67% and 55% for outpatient and residential treatment, respectively.
- Medication-assisted therapy has given patients with addiction new hope and a better prognosis for ongoing sustained recovery. Medication-Assisted Treatment is proven, in study after study, to produce the most successful treatment outcomes.1
- Effective, evidence-based treatment for opioid addiction “must include four basic elements: detoxification, rehabilitative counseling, continuing care, and Medication-Assisted Therapy.”3
At Symetria, our success rate is 4x the industry average. Our data also shows:
- After six months 9 in 10 patients are having success in treatment.
- Only 13% of patients returned to use of addictive substances at one year follow up.
- 99% of patients did not require admission to a higher level of care than we offer onsite.
- 80% of patients participated in preventive health screenings and immunizations.
- 92% of patients were able to avoid unplanned hospitalization.
- 80% of patients were able to reduce or abstain from tobacco use.
- 96% of patients were able to reduce or abstain from alcohol use.
- Average time in treatment is 9 months across medication programs.
- American Society of Addiction Medicine (ASAM), “The impact of managed care on addiction treatment: an analysis;” Thomas, C, et al. (2014). Medication-Assisted Treatment with Buprenorphine: Assessing the Evidence. Psychiatric Services, 65, 11-15.
- National Quality Forum Standards for Treatment of Substance Use Disorders 2007.
- ASAM; National Quality Forum Standards for Treatment of Substance Use Disorders 2007. Each of these four essential elements is present in Symetria Recovery’s treatment model.
Get Help Fighting Opioid Addiction Today
If you’ve been worried about a loved one, or if you’re concerned about the way you use your pain medication, we urge you to contact us as soon as possible for help. To take the first step, contact us online or call right away.
Symetria Recovery’s success rate is 4x greater than the industry average.
After six months, 9 in 10 patients are having success in treatment.
Only 13% of patients returned to use of addictive substances at one year follow up.
99% of patients did not require admission to a higher level of care than we offer onsite.
The proof is in the numbers